Golden State Equity Partners Abbott Laboratories Transaction History
Golden State Equity Partners
- $402 Million
- Q4 2023
A detailed history of Golden State Equity Partners transactions in Abbott Laboratories stock. As of the latest transaction made, Golden State Equity Partners holds 5,373 shares of ABT stock, worth $557,287. This represents 0.15% of its overall portfolio holdings.
Number of Shares
5,373
Previous 4,830
11.24%
Holding current value
$557,287
Previous $467,000
26.55%
% of portfolio
0.15%
Previous 0.13%
Shares
7 transactions
Others Institutions Holding ABT
# of Institutions
3,115Shares Held
1.29BCall Options Held
8.43MPut Options Held
8.19M-
Vanguard Group Inc Valley Forge, PA165MShares$17.1 Billion0.38% of portfolio
-
Black Rock Inc. New York, NY133MShares$13.8 Billion0.36% of portfolio
-
Capital Research Global Investors Los Angeles, CA84MShares$8.71 Billion2.23% of portfolio
-
State Street Corp Boston, MA74.7MShares$7.75 Billion0.39% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$7.28 Billion1.65% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $182B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...